• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼吸医学中的微生物组:当前的挑战和未来的展望。

The microbiome in respiratory medicine: current challenges and future perspectives.

机构信息

Hospital Clinic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.

CIBER de Enfermedades Respiratorias - CIBERES, Madrid, Spain.

出版信息

Eur Respir J. 2017 Apr 12;49(4). doi: 10.1183/13993003.02086-2016. Print 2017 Apr.

DOI:10.1183/13993003.02086-2016
PMID:28404649
Abstract

The healthy lung has previously been considered to be a sterile organ because standard microbiological culture techniques consistently yield negative results. However, culture-independent techniques report that large numbers of microorganisms coexist in the lung. There are many unknown aspects in the field, but available reports show that the lower respiratory tract microbiota: 1) is similar in healthy subjects to the oropharyngeal microbiota and dominated by members of the Firmicutes, Bacteroidetes and Proteobacteria phyla; 2) shows changes in smokers and well-defined differences in chronic respiratory diseases, although the temporal and spatial kinetics of these changes are only partially known; and 3) shows relatively abundant non-cultivable bacteria in chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, cystic fibrosis and bronchiectasis, with specific patterns for each disease. In all of these diseases, a loss of diversity, paralleled by an over-representation of Proteobacteria (dysbiosis), has been related to disease severity and exacerbations. However, it is unknown whether dysbiosis is a cause or a consequence of the damage to bronchoalveolar surfaces.Finally, little is known about bacterial functionality and the interactions between viruses, fungi and bacteria. It is expected that future research in bacterial gene expressions, metagenomics longitudinal analysis and host-microbiome animal models will help to move towards targeted microbiome interventions in respiratory diseases.

摘要

健康的肺以前被认为是一个无菌的器官,因为标准的微生物培养技术总是产生阴性结果。然而,非培养技术报告说,大量的微生物共存于肺部。该领域有许多未知的方面,但现有报道表明,下呼吸道微生物群:1)在健康受试者中与口咽微生物群相似,以厚壁菌门、拟杆菌门和变形菌门的成员为主;2)在吸烟者中发生变化,在慢性呼吸道疾病中存在明确的差异,尽管这些变化的时空动力学仅部分为人所知;3)在慢性阻塞性肺疾病、特发性肺纤维化、囊性纤维化和支气管扩张症中显示出相对丰富的不可培养细菌,每种疾病都有特定的模式。在所有这些疾病中,多样性的丧失,伴随着变形菌门(失调)的过度表达,与疾病的严重程度和恶化有关。然而,尚不清楚失调是气道肺泡表面损伤的原因还是结果。最后,关于细菌功能以及病毒、真菌和细菌之间的相互作用知之甚少。预计未来在细菌基因表达、宏基因组纵向分析和宿主-微生物组动物模型方面的研究将有助于针对呼吸道疾病的微生物组干预措施。

相似文献

1
The microbiome in respiratory medicine: current challenges and future perspectives.呼吸医学中的微生物组:当前的挑战和未来的展望。
Eur Respir J. 2017 Apr 12;49(4). doi: 10.1183/13993003.02086-2016. Print 2017 Apr.
2
The role of the bacterial microbiome in lung disease.细菌微生物组在肺部疾病中的作用。
Expert Rev Respir Med. 2013 Jun;7(3):245-57. doi: 10.1586/ers.13.24.
3
The microbiome and emerging pathogens in cystic fibrosis and non-cystic fibrosis bronchiectasis.囊性纤维化和非囊性纤维化支气管扩张中的微生物群与新出现的病原体
Semin Respir Crit Care Med. 2015 Apr;36(2):225-35. doi: 10.1055/s-0035-1546752. Epub 2015 Mar 31.
4
Dysbiosis of lower respiratory tract microbiome are associated with inflammation and microbial function variety.下呼吸道微生物组的失调与炎症和微生物功能多样性有关。
Respir Res. 2019 Dec 3;20(1):272. doi: 10.1186/s12931-019-1246-0.
5
[The lung microbiome in 2015: a window on chronic lung diseases].《2015年的肺部微生物群:洞察慢性肺部疾病的窗口》
Med Sci (Paris). 2015 Nov;31(11):971-8. doi: 10.1051/medsci/20153111011. Epub 2015 Nov 17.
6
The development of lower respiratory tract microbiome in mice.小鼠下呼吸道微生物组的发育。
Microbiome. 2017 Jun 21;5(1):61. doi: 10.1186/s40168-017-0277-3.
7
Host-microbe interactions in distal airways: relevance to chronic airway diseases.远端气道中的宿主-微生物相互作用:与慢性气道疾病的相关性
Eur Respir Rev. 2015 Mar;24(135):78-91. doi: 10.1183/09059180.00011614.
8
Lung inflammation and disease: A perspective on microbial homeostasis and metabolism.肺部炎症和疾病:从微生物内稳态和代谢角度看。
IUBMB Life. 2019 Feb;71(2):152-165. doi: 10.1002/iub.1969. Epub 2018 Nov 22.
9
Role of the Lung Microbiome in the Pathogenesis of Chronic Obstructive Pulmonary Disease.肺微生物组在慢性阻塞性肺疾病发病机制中的作用。
Chin Med J (Engl). 2017 Sep 5;130(17):2107-2111. doi: 10.4103/0366-6999.211452.
10
Oral-lung microbiome interactions in lung diseases.肺部疾病中的口咽-肺部微生物组相互作用。
Periodontol 2000. 2020 Jun;83(1):234-241. doi: 10.1111/prd.12301.

引用本文的文献

1
Microbial Interconnections in One Health: A Critical Nexus Between Companion Animals and Human Microbiomes.“同一健康”中的微生物联系:伴侣动物与人类微生物组之间的关键纽带
Microorganisms. 2025 Jul 3;13(7):1564. doi: 10.3390/microorganisms13071564.
2
Leveraging transcriptome-wide association studies identifies the relationship between upper respiratory flora and cell type-specific gene expression in severe respiratory disease.利用全转录组关联研究确定了严重呼吸道疾病中上呼吸道菌群与细胞类型特异性基因表达之间的关系。
PLoS One. 2025 May 9;20(5):e0322864. doi: 10.1371/journal.pone.0322864. eCollection 2025.
3
From Microbial Ecology to Clinical Challenges: The Respiratory Microbiome's Role in Antibiotic Resistance.
从微生物生态学到临床挑战:呼吸道微生物群在抗生素耐药性中的作用
Pathogens. 2025 Apr 5;14(4):355. doi: 10.3390/pathogens14040355.
4
Post-viral lung diseases: the microbiota as a key player.病毒感染后肺部疾病:微生物群作为关键因素
ERJ Open Res. 2025 Apr 7;11(2). doi: 10.1183/23120541.00560-2024. eCollection 2025 Mar.
5
Deciphering respiratory viral infections by harnessing organ-on-chip technology to explore the gut-lung axis.利用芯片器官技术探索肠-肺轴来解析呼吸道病毒感染
Open Biol. 2025 Mar;15(3):240231. doi: 10.1098/rsob.240231. Epub 2025 Mar 5.
6
The Gut Microbiota-Related Antihyperglycemic Effect of Metformin.二甲双胍与肠道微生物群相关的降血糖作用
Pharmaceuticals (Basel). 2025 Jan 6;18(1):55. doi: 10.3390/ph18010055.
7
Nebulization of 2% lidocaine has no detectable impact on the healthy equine respiratory microbiota.雾化2%利多卡因对健康马的呼吸道微生物群没有可检测到的影响。
PLoS One. 2025 Jan 24;20(1):e0316079. doi: 10.1371/journal.pone.0316079. eCollection 2025.
8
The microbiome is dispensable for normal respiratory function and chemoreflexes in mice.微生物群对小鼠的正常呼吸功能和化学反射并非必需。
Front Physiol. 2024 Dec 6;15:1481394. doi: 10.3389/fphys.2024.1481394. eCollection 2024.
9
Lower respiratory tract microbiota in patients with clinically suspected nontuberculous mycobacterial pulmonary disease according to the presence of gastroesophageal reflux.根据胃食管反流情况,分析疑似非结核分枝杆菌肺病患者的下呼吸道微生物群。
PLoS One. 2024 Aug 28;19(8):e0309446. doi: 10.1371/journal.pone.0309446. eCollection 2024.
10
Microbiome-host interactions in the pathogenesis of acute exacerbation of chronic obstructive pulmonary disease.微生物组-宿主相互作用在慢性阻塞性肺疾病急性加重发病机制中的作用。
Front Cell Infect Microbiol. 2024 Jul 18;14:1386201. doi: 10.3389/fcimb.2024.1386201. eCollection 2024.